- According to estimates from 13 analysts, West Pharmaceutical Services, Inc. stock's average price target has risen from $367.15 to $370.23, with forecasts ranging from $340 to $410 per share
- Based on the Jul. 8 closing price, the updated target implies approximately 5% potential upside
- Consensus rating remains at “Buy” across 18 covering analysts, with 15 Buys, 2 Holds and 1 Sells
Explore more price target data and ratings for West Pharmaceutical Services, Inc. on the , and track all previous and future analyst recommendations for West Pharmaceutical Services, Inc. in the dedicated .
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.